NCT00028106View on ClinicalTrials.gov

131MIBG to Treat Malignant Pheochromocytoma

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 5, 2001

Study Completion Date

January 8, 2007

Conditions
Pheochromocytoma
Interventions
DRUG

[131]I-MIBG

DRUG

6-[18F]Fluorodopamine

DRUG

[123]I-MIBG

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00028106 - 131MIBG to Treat Malignant Pheochromocytoma | Biotech Hunter | Biotech Hunter